Dr Reddy’s Laboratories (RDY) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Dr. Reddy’s Laboratories Limited has successfully adhered to statutory compliance regulations and good corporate practices for the financial year ending March 31, 2024, as verified by the company’s secretarial audit. The company maintained compliance with all the relevant provisions of the SEBI Act, SCRA, and various other SEBI regulations without reporting any deviations. This compliance report affirms Dr. Reddy’s commitment to regulatory adherence and transparency with stakeholders in the financial markets.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
